Ignite Creation Date:
2025-12-24 @ 11:46 PM
Ignite Modification Date:
2026-01-01 @ 10:13 PM
Study NCT ID:
NCT06627751
Status:
SUSPENDED
Last Update Posted:
2025-11-17
First Post:
2024-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Sponsor:
Roswell Park Cancer Institute
Organization: